SR

Sankaraiah Rajagopal

Active Director Director DIN 00025022
DIN 00025022 First appointment Jun 2003 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Past companies 21 historical roles
Total affiliations 28 Since Jun 2003
Shareholding value Locked Premium profile

About Sankaraiah Rajagopal

Sankaraiah Rajagopal has 23 years in corporate governance. Holds Director and Designated Partner roles. Currently with 7 companies, including Speciality Molecules Limited and Jubilant Innovation (India) Limited. Formerly with 21 companies, such as Jubilant E & P Ventures Private Limited and Jubilant Biosys Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.

DIN 00025022
Primary Designation Director
First Appointment 27 Jun 2003
Oldest Company Age 28 yrs

Current companies

Company Designation Appointment Founded Status
Strafin Solutions Llp AAR-7193
Designated Partner 24 Jan 2020 2020 Active
Apex Heart Care Private Limited U85110DL2002PTC114118
Director 29 Oct 2025 2002 Active
Continental Advance System (India) Limited U29100DL2007PLC158565
Director 29 Jan 2025 2007 Active
Baxy Foundation U85500HR2025NPL131300
Director 25 Apr 2025 2025 Active
Baxy Engineering Limited U29104DL2023PLC411307
Director 24 Jul 2024 2023 Active
Baxy Limited U34100DL2015PLC279347
Director 13 Apr 2023 2015 Active
Baxy Mobility Limited U30912DL2023PLC421175
Director 12 Oct 2023 2023 Active

Previous companies

Company Designation Appointment Founded Status
Jubilant E & P Ventures Private Limited U11103UP2006PTC043500
Director 16 Sep 2006 2006 Amalgamated
Jubilant Biosys Limited U24110UP1998PLC029591
Director 27 Jun 2003 1998 Active
Jubilant Draximage Limited U74900UP2009FLC038194
Director 09 Sep 2009 2009 Active
Jubilant Infrastructure Limited U45201UP2006PLC031618
Director 17 Apr 2006 2006 Active
Jubilant Chemsys Limited U24232UP2004PLC029009
Director 30 Aug 2004 2004 Amalgamated
Jubilant Industries Limited L24100UP2007PLC032909
Director 03 Dec 2009 2007 Amalgamated
Asia Healthcare Development Limited U85110KA2004PLC078947
Additional Director 13 Mar 2008 2004 Active
Axis Finvest Advisory Private Limited U74999MH2006PTC161204
Director 20 Jun 2006 2006 Converted To Llp
Speciality Molecules Limited U24119UP1998PLC037398
Director 03 Jun 2008 1998 Amalgamated
Jubilant Innovation (India) Limited U73100UP2007PLC034211
Director 29 Nov 2007 2007 Dissolved (Liquidated)
First Trust Medicare Private Limited U85110UP2007PTC059859
Director 12 Oct 2011 2007 Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Speciality Molecules Limited
Jubilant Innovation (India) Limited
First Trust Medicare Private Limited
Strafin Solutions Llp
Premium access

Shareholding and investment profile for Sankaraiah Rajagopal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sankaraiah Rajagopal

Sankaraiah Rajagopal has 23 years in corporate governance. Holds Director and Designated Partner roles. Currently with 7 companies, including Speciality Molecules Limited and Jubilant Innovation (India) Limited. Formerly with 21 companies, such as Jubilant E & P Ventures Private Limited and Jubilant Biosys Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.

Sankaraiah Rajagopal is associated with 7 companies as Director and Designated Partner.

Sankaraiah Rajagopal has expertise in General Business, Healthcare.

Sankaraiah Rajagopal has 23 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available